» Articles » PMID: 18828969

Effect of Baseline Glomerular Filtration Rate on Survival in Patients Undergoing Partial or Radical Nephrectomy for Renal Cortical Tumors

Overview
Journal Mayo Clin Proc
Specialty General Medicine
Date 2008 Oct 3
PMID 18828969
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the effect of baseline renal function and comorbidity index on survival in patients with renal tumors.

Patients And Methods: We retrieved demographic, clinicopathologic, body mass index (BMI), and comorbidity data (assessed by Charlson-Romano index and hypertension) for 1479 patients who underwent partial or radical nephrectomy between January 4, 1995, and June 9, 2005, for localized renal tumors. We used the abbreviated Modified Diet and Renal Disease equation to estimate glomerular filtration rate (eGFR) using the last preoperative serum creatinine measurement. Body mass index and eGFR time trends were analyzed with linear regression. The effect of BMI, comorbidity, and baseline eGFR on disease-free and overall survival was studied using Cox regression controlling for pathologic stage, nodal status, and metastasis.

Results: Over a 10-year interval, median BMI increased from 27 (interquartile range [IQR], 24-31) to 28 (IQR, 25-31; P=.004), and median baseline eGFR decreased from 70 (IQR, 58-80) to 63 mL/min per 1.73 m(2) (IQR, 57-78; P<.001). Multivariate regression demonstrated an association between year of surgery and baseline eGFR (P<.001) even after adjusting for age, sex, comorbidity, BMI, and tumor size. We repeated the analysis for patients aged 18 to 70 years, and this association persisted (P<.001). Baseline eGFR, BMI, and comorbidity were not associated with disease-free survival after controlling for stage. However, moderately reduced baseline eGFR (45-60 mL/min per 1.73 m(2)) and severely reduced eGFR (<45 mL/min per 1.73 m(2)) were significantly associated with overall survival (hazard ratio, 1.5; P<.003; and hazard ratio, 2.8; P<.001; respectively).

Conclusion: Baseline eGFR has declined over the past decade. Nephron-sparing techniques should be considered for patients with severely diminished baseline eGFR.

Citing Articles

Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy.

Gonzalez-Ginel I, Hernandez-Arroyo M, Garcia-Rayo C, Gomez-Del-Canizo C, Rodriguez-Antolin A, Guerrero-Ramos F J Clin Med. 2024; 13(21).

PMID: 39518445 PMC: 11546053. DOI: 10.3390/jcm13216305.


An Evaluation of a Web-Based Decision Aid for Treatment Planning of Small Kidney Tumors: Pilot Randomized Controlled Trial.

Fogarty J, Siriruchatanon M, Makarov D, Langford A, Kang S JMIR Res Protoc. 2022; 11(9):e41451.

PMID: 36053558 PMC: 9482069. DOI: 10.2196/41451.


Development and Pilot Evaluation of a Decision Aid for Small Kidney Masses.

Thomas S, Siriruchatanon M, Albert S, Bjurlin M, Hoffmann J, Langford A J Am Coll Radiol. 2022; 19(8):935-944.

PMID: 35714722 PMC: 9357200. DOI: 10.1016/j.jacr.2022.05.017.


Partial Nephrectomy in pT3a Tumors Less Than 7 cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy.

Ziegelmueller B, Spek A, Szabados B, Casuscelli J, Buchner A, Stief C Cureus. 2019; 11(9):e5781.

PMID: 31723540 PMC: 6825485. DOI: 10.7759/cureus.5781.


Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.

Hamilton Z, Capitanio U, Lane B, Larcher A, Yim K, Dey S World J Urol. 2019; 37(11):2429-2437.

PMID: 30710156 DOI: 10.1007/s00345-019-02650-9.


References
1.
Fox C, Larson M, Leip E, Culleton B, Wilson P, Levy D . Predictors of new-onset kidney disease in a community-based population. JAMA. 2004; 291(7):844-50. DOI: 10.1001/jama.291.7.844. View

2.
Muntner P, He J, Hamm L, Loria C, Whelton P . Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002; 13(3):745-753. DOI: 10.1681/ASN.V133745. View

3.
Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

4.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

5.
Romano P, Roos L, Jollis J . Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993; 46(10):1075-9; discussion 1081-90. DOI: 10.1016/0895-4356(93)90103-8. View